Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
China’s YishengBio is going to Nasdaq, making the transition via $230M SPAC maneuver
3 years ago
China
'Structure, beauty and clarity': With seed financing, Kaleidoscope aims to synchronize R&D teams
3 years ago
Startups
Bristol Myers got the first TYK2 approval. Frazier’s new biotech Sudo hopes to get many more
3 years ago
Startups
A new ADC biotech looks to revive secretive platform, secures Big VC backing
3 years ago
Startups
George Church’s woolly mammoth revival biotech Colossal spins out computational bio outfit
3 years ago
Startups
Liver-focused startup nabs $115M in exchange for rare disease drug royalties
3 years ago
They’re going for it: David Liu’s preclinical biotech shoots for a (maybe $200M) IPO
3 years ago
Precision oncology biotech agrees to $72M cash infusion as it seeks to increase revenue
3 years ago
AbbVie expands manufacturing presence in Ireland with a €60M investment
3 years ago
Manufacturing
Weight loss player gets attention of RA Capital, walks away with $132M to keep pursuing big targets
3 years ago
From clinical fail to raising cash? Virios goes for public offering as shares reach all-time low
3 years ago
TCR upstart gets fresh funding as it looks to charge toward the clinic
3 years ago
Startups
Cell/Gene Tx
Following program cuts and amid drug launch, Roivant lines up $1B shelf registration
3 years ago
One SPAC's journey to find a partner, and its race against the clock, shows toughness of bear market
3 years ago
Deals
Ventyx seeks to rack up $176M+ in its latest move as the market become bullish on TYK2
3 years ago
R&D
With hit-and-miss data, Allakos goes the public offering route in $150M ask
3 years ago
The virus shredder: A Princeton spinout advised by a high-profile VC launches a Cas13 viral defense system
3 years ago
From three companies to one — Galvanize Therapeutics gets $100M to push electric field therapy
3 years ago
Startups
First of more? Third Harmonic prices upsized IPO to raise $185M
3 years ago
Genentech-partnered Novome lands $43.5M to push gastrointestinal drug through mid-stage study
3 years ago
With positive PhII NASH data in tow, Akero opens $175M public offering
3 years ago
Takeda’s manufacturing site in Belgium gets a €300M boost for plasma therapy production
3 years ago
Manufacturing
A $105M SPAC deal? Really? A biotech with deep China roots is making a now-rare flip onto Nasdaq
3 years ago
Backed by five pharma giants and a crew of Penn superstars, a startup uses mRNA to create in vivo CAR-T — with a pro at the helm
3 years ago
Startups
Cell/Gene Tx
First page
Previous page
46
47
48
49
50
51
52
Next page
Last page